Lionsgate Studios stock dips in premarket as traders eye CFO talk after Friday’s 9% jump

Lionsgate Studios stock dips in premarket as traders eye CFO talk after Friday’s 9% jump

March 2, 2026

New York, March 2, 2026, 08:57 EST — Premarket

  • Shares of Lionsgate Studios slipped roughly 1% ahead of the bell, giving back a bit of ground following Friday’s strong rally.
  • The company’s CFO is scheduled to speak at a Morgan Stanley conference this Wednesday.
  • Investors want new details on upcoming film releases and the appetite for licensing deals.

Lionsgate Studios Corp slipped roughly 1% to $8.92 before the bell Monday, pulling back after Friday’s 9.1% rally that left shares at $9.00. Over the last year, the stock’s range has spanned from $5.55 up to $10.09, market data show.

This one could move the needle—Lionsgate, a name with thin liquidity, lands on watchlists ahead of a scheduled appearance this week that has the potential to jolt short-term positioning. According to the company’s investor site, CFO Jimmy Barge is set for a fireside chat at the Morgan Stanley Technology, Media, and Telecom Conference on March 4.

Shareholder business is the next thing on deck. Lionsgate Studios, according to a company filing, has scheduled its first annual general and special meeting for March 17.

Shares took off in late February, after a wave of focus hit the stock in the wake of Lionsgate’s latest results. On Feb. 5, the studio reported third-quarter revenue of $724.3 million, alongside operating income of $36.0 million. Adjusted OIBDA—a measure that excludes interest, taxes and some non-cash expenses—came in at $85.3 million. “Keeps us on track” for fiscal 2026 goals, CEO Jon Feltheimer said. PR Newswire

The library draws investor attention for its steady stream of licensing fees, cash that comes in every time older titles get resold to platforms and broadcasters. If that revenue line falters, shares often move as well.

Lionsgate’s corporate fact sheet from last month maps out a January to March slate and highlights key industry dates like South by Southwest, running March 12–18, as potential catalysts for deal talk. Among the projects listed: theatrical and TV releases anchored to franchises including John Wick, The Hunger Games, Twilight, and Saw.

It was an active Friday for Lionsgate, with the investor quote page displaying over 6.6 million shares changing hands—far beyond the stock’s usual volume on less eventful days. That surge tends to attract fast-moving traders, who are just as quick to exit as they are to pile in.

Yet what really shapes the next few sessions might not be the tape but the comments executives make in public. Sometimes a conference appearance is nothing special. Other times, though, it brings out fresh information—spending plans, upcoming releases, or signals on demand from both streaming platforms and legacy buyers.

Here’s the risk: Should Wednesday’s remarks lack detail, or if executives sound hesitant about timelines, shares might shed part of last week’s rally. Film and TV revenue stays unpredictable—just one delayed release can shift sales across quarters.

Traders have their eyes on Wednesday’s Morgan Stanley chat, looking for any change in tone regarding the slate and licensing. Next up on the calendar: the March 17 shareholder meeting.

Konrad Wysocki

Konrad Wysocki is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Rzeszów, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

Stock Market Today

  • EchoIQ (ASX: EIQ) up after Pro Medicus deal, $110M raise
    July 30, 2026, 3:43 AM EDT. EchoIQ (ASX: EIQ) gained 1.59% to AUD 1.28 on July 30, 2026, after a quarterly report. The company set plans for a $20 million investment and a commercial tie-up with Pro Medicus Limited (ASX: PME), aiming for broader reach in a big US healthcare network. EchoIQ also wrapped up a $110 million institutional placement to boost its US expansion and speed work on its AI EchoSolv heart platform. Processed echocardiograms rose 20% in the quarter as more users came on. The report points to EchoIQ pushing growth through new partners and more capital.